End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- PTS | -.--% |
|
-.--% | -.--% |
06-11 | Transcript : Docebo Inc. - Shareholder/Analyst Call | |
05-13 | Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- With an expected P/E ratio at 79.44 and 53.74 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 7.01 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 1.15B | - | ||
+19.54% | 3,374B | C+ | ||
+14.45% | 86.53B | B+ | ||
+66.98% | 63.85B | D+ | ||
-22.93% | 49.62B | B+ | ||
+40.29% | 48.96B | D+ | ||
-22.99% | 46.84B | B- | ||
+75.85% | 41.28B | D+ | ||
-4.26% | 26.83B | C+ | ||
-9.71% | 26.31B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- DCBO Stock
- DCBO Stock
- Ratings Docebo Inc.